[CITATION][C] Factors associated with poor outcomes of hospitalized myasthenia gravis

SS Tin, V Wiwanitkit - Neurosciences Journal, 2015 - nsj.org.sa
We would like to discuss the recent publication by Tiamkao et al1 entitled 'Factors
associated with poor outcomes of hospitalized myasthenia gravis'. Tiamkao et al1 noted that …

Factors associated with poor outcomes of hospitalized myasthenia gravis

V Wiwanitkit - nsj.org.sa
We would like to discuss the recent publication by Tiamkao et al1 entitled 'Factors
associated with poor outcomes of hospitalized myasthenia gravis'. Tiamkao et al1 noted that …

Clinical outcome and predictive factors of postoperative myasthenic crisis in 173 thymomatous myasthenia gravis patients: methodological issues

A Ashrafi-Asgarabada, S Safiri - International Journal of …, 2018 - Taylor & Francis
Sir, We read the article by Li and colleagues with great interest [1]. The authors purposed to
determine the clinical outcome and predictors of postoperative myasthenic crisis (POMC) in …

Predictors of outcome of myasthenic crisis

N Liu, Q Liu, X Wu, K Liu, Q Vadis - Neurological Sciences, 2015 - Springer
Dear Editor, We read with great interest the article by Kalita and colleagues [1]. They found
that male gender, recurrent infection, bulbar weakness, titer of antibodies (Abs) against …

Prevalence of factors associated with poor outcomes of hospitalized myasthenia gravis patients in Thailand

S Tiamkao, S Pranboon, K Thepsuthammarat… - Neurosciences …, 2014 - nsj.org.sa
Objective: To examine the prevalence of hospitalized myasthenia gravis (MG), and to
determine the factors associated with poor outcomes of hospitalized MG patients at a …

HLA class II polymorphism contribution to disease severity and response to treatment in myasthenia gravis

F Sinaei, S Nafissi, F Fatehi, SO Gharan… - Journal of the …, 2019 - jns-journal.com
Background As many autoimmune disorders, myasthenia gravis (MG) is the result of genetic
and environmental interactions. MHC class II polymorphism has well-known predisposing …

Impact of Medications on Myasthenia Gravis Patient Population at University Hospital (P3. 121)

R Gummi, N Kukulka, R Govindarajan - 2017 - AAN Enterprises
Objective: Assess the proportion of myasthenia gravis exacerbations which involve
medications that are advised against by the MGFA. Assess the type of medications most …

Human Leukocyte Antigen Class II associations in late‐onset Myasthenia Gravis

G Spagni, L Todi, G Monte, M Valentini… - Annals of Clinical …, 2021 - Wiley Online Library
Objective Genetic factors predisposing to late‐onset myasthenia gravis (LOMG) have not
been clearly defined yet. However, genome‐wide association studies identified Human …

Clinical features and impact of myasthenia gravis disease in Australian patients

S Blum, D Lee, D Gillis, DF McEniery, S Reddel… - Journal of Clinical …, 2015 - Elsevier
We performed a community-based survey of 165 Australian patients with a physician-
confirmed diagnosis of myasthenia gravis (MG). MG is an autoimmune disease of the …

Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese.

WH Chen, HC Chiu, RP Hseih - Journal of Neurology, Neurosurgery …, 1993 - jnnp.bmj.com
One hundred and fifty two Chinese patients with myasthenia gravis in Taiwan were
investigated for HLA-A, B, C and DR/DQ typing. HLA-Bw46 and DR9 frequencies were …